Key result
Lack of high-quality evidence hinders reducing anesthesia care variation, challenging variation-driven clinical trial agendas.
Why the study?
Although clinical medicine aims to reduce variation in care to improve outcomes and lower costs, many aspects of anesthesia lack high quality evidence, raising uncertainty about whether desires to reduce variation should drive the clinical trial agenda.
Answers are grounded in this paper and cite their sources.
Questions prioritizing variation reduction for anesthesia trials; leaves open the optimal evidence-based research agenda.
In clinical medicine there is a strong drive to reduce variation of care.Should desires to reduce variation of care drive our clinical trial agenda?In principle, reducing variation in care should be a good thing.Reducing variation can improve outcomes and reduce costs.This is due to: a) reducing error and improving the reliability, speed and skill base as the clinician and hospital follow increasingly familiar care pathways and b) adopting only practices where there is good evidence for better outcomes.The problem is that in many aspects of anesthesia there is not a lot of high quality
No takes yet. Share an insight, caveat, or question.
Andrew Davidson (2020) reported an editorial. Reducing variation in care in anesthesia is hindered by a lack of high-quality evidence, raising questions about whether variation should drive the clinical trial agenda.
Synapse has enriched 10 related papers. Consider them for comparative context: